Zdrowie i gospodarka · 31/08/2004

FDA's Center for Biologics Evaluation and Research Hosts Public Workshop to Discuss Scientific Opportunities for Vaccine and Blood Product Development

The Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) is hosting a public workshop to explore ways to facilitate the development of vaccines, blood products, and cellular, tissue, and gene therapies, with the goal of bringing these innovative treatments to consumers more quickly.